Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

EARNINGS: Next 15 profit falls; 4basebio and Mollyroe losses widen

1st Oct 2025 12:57

(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Monday and Tuesday and not separately reported by Alliance News:

----------

Next 15 Group PLC - London-based digital marketing firm - Reports pretax profit of GBP2.8 million for six months to July 31, down sharply from GBP33.4 million a year prior, due to Mach49 write-downs and related advisory costs. Adjusted pretax profit eases 1.4% to GBP30.9 million from GBP31.4 million, while revenue falls 11% to GBP324.2 million from GBP364.1 million. Net revenue dips to GBP230.8 million from GBP239.4 million. Adjusted diluted earnings per share edge up to 21.4 pence from 20.8p, while statutory diluted earnings per share swing to a 1.4p loss from a 21.1p profit. Interim dividend is maintained at 4.75p. Says trading in the first months of the second half is progressing as expected and expects full-year performance to be in line with market expectations. Chief Executive Sam Knights says: "In my first 100 days as CEO, we have acted decisively to resolve legacy issues, simplify the Group, and position the business for sustainable growth."

----------

Globe Capital Ltd - Cayman Island-based worldwide marketing company - Reports pretax loss of GBP68,000 for six months to June 30, widening from GBP54,000 a year prior, as administrative expenses increased to GBP61,000 from GBP49,000. No revenue generated, unchanged from the year before. Basic and diluted loss per share is 0.03 pence, compared with 0.02p. Chair Simon Grant Rennick says the company "continues to be an active investor" and remains well placed to take advantage of opportunities through 2025.

----------

4basebio PLC - Cambridge, England-based life sciences company and manufacturer of synthetic DNA products - Posts pretax loss of GBP8.2 million for six months to June 30, widening from GBP6.1 million a year earlier, as administrative expenses rise to GBP8.9 million from GBP6.3 million. Revenue increases to GBP1.2 million from GBP328,000, while cost of goods sold climb to GBP473,000 from GBP92,000. Basic and diluted loss per share widens to 0.50 pence from 0.45p. Chari Manja Boerman says the company expects to continue to grow its pipeline, client base and revenue in the second half, supported by recent MHRA regulatory approval and strong cash reserves of GBP26.1 million. "We are very pleased with the progress in the first half of the year in particular in relation to revenue growth and MHRA regulatory approval. The half year also saw an important client secure FDA IND approval for a mRNA vaccine manufactured using 4basebio DNA with other clients progressing their programs towards the clinic," Boerman said.

----------

Mollyroe PLC - company focused on finding investment opportunities in spatial computing and intelligent natural interfaces - Reports pretax loss of GBP75,915 for six months to June 30, widening from GBP43,949 a year earlier, as administrative expenses rise to GBP77,499 from GBP46,250. Declares no revenue, unchanged from prior year. Basic and diluted loss per share narrows to 0.19 pence from 0.30p. Chair Noel Lyons says Mollyroe remains focused on backing "breakthroughs" such as its recent investment in Cascade Studio, an AI-powered filmmaking platform, and expects it to be "transformational."

----------

abrdn Property Income Trust Ltd - Guernsey-registered investment trust that seeks higher yield and capital growth from active management of UK real estate - Posts IFRS loss per share of 0.4 pence for six months to June 30, narrowing from 3.0p a year prior, reflecting a valuation reduction at its Far Ralia land asset. Declares no interim dividend, compared with 2.0p per share a year ago. Net asset value per share falls to 7.5p from 8.0p at December 31, with net assets down to GBP28.7 million from GBP30.4 million. Chair Mike Balfour says focus remains on progressing liquidation through the disposal of Far Ralia and finalising matters related to last year’s sale of subsidiaries to GoldenTree.

----------

Critical Mineral Resources PLC - exploration and development of clean energy metals in Morocco - Reports pretax loss of GBP445,525 for the six months to June 30, widening from GBP279,249 a year before, as administrative expenses rise to GBP390,951 from GBP280,002. Posts basic and diluted loss per share of 0.3 pence, compared with 0.5p. Notes formal joint venture agreement signed in May for Agadir Melloul copper project in Morocco, with GBP1.1 million advanced to fund drilling, exploration, and permits. Raises GBP2.2 million during the period through equity and convertible loan notes. CEO Charles Long says: "H1 2025 was very significant for CMR and its shareholders. We signed the formal joint venture agreement for Agadir Melloul and secured cornerstone finance. This finance, provided by our largest shareholder, followed nearly 3 months of technical and corporate due diligence, including a site visit by an independent mining consultant whose very positive technical report formed the basis of the investment decision"

----------

London & Associated Properties PLC - London-based investor in UK industrial and retail properties - Reports pretax loss of GBP3.0 million for the six months to June 30, compared with profit of GBP4.2 million a year earlier, as operating costs rise to GBP28.3 million from GBP20.0 million. Revenue increases to GBP26.1 million from GBP24.8 million. Net assets attributable to shareholders fall to GBP26.7 million at June 30 from GBP28.1 million at December 31, equal to 31.33 pence per share from 32.91p. Says property portfolio maintains strong tenant demand, with occupancy at around 94% by rental income, versus 96% a year before. Chair & CEO John Heller says the group continues to explore opportunities to cut overheads and restore profitability.

----------

Oberon Investments Group PLC - London-based boutique investment management, wealth planning and corporate broking - Reports net asset value per share of 28.1 pence at June 30, up from 25.8p at December 31, 2024, driven by portfolio gains and new investment inflows. Says NAV increases 9.0% in the first half, outperforming the FTSE AIM All-Share Index's 7.1% rise. Notes two new investments in GeninCode PLC and Oxford BioDynamics PLC, plus follow-on investments in Seeen PLC and Belluscura PLC. Exits or top-slices eight holdings to crystallise gains and rebalance portfolio. Says market sentiment towards UK smaller firms has improved, and the outlook for the second half of 2025 is positive.

----------

Anglesey Mining PLC - mining company with operations in Wales, Sweden and Canada - Reports no revenue for financial year ended March 31, unchanged from a year prior. Pretax loss narrows to GBP656,504 from GBP1.2 million. Basic and diluted loss per share is 0.1 pence versus 0.3p. Net assets edge down to GBP14.3 million from GBP14.5 million. Says focus remains on advancing the development of a polymetallic underground mine at Parys Mountain.

----------

By Eva Castanedo, Alliance News reporter

Comments and questions to [email protected]

Copyright 2025 Alliance News Ltd. All Rights Reserved.


Related Shares:

GenincodeOxford BiodynSeeenBelluscuraAnglesey MiningLondon & Associated PropertiesCritical MinAbrdn Property4basebio PlcNext 15 Group
FTSE 100 Latest
Value9,441.75
Change91.32